Monthly Archives: October 2016

Archive of posts published in the specified Month

Oct
30

OWCP: Near-Future Acquisition Candidate?

This is obviously a pure speculation / hypothetical article.  There’s absolutely no public evidence available right now that suggests OWCP is currently being considered by Big Pharma, but we know TEVA was interested in July 2015.  We also know, by an easy Google search,…

Oct
20

OWCP: New 52-Week High on News!

Upon the News Release on October 20th, 2016, OWCP has reached a new 52-week high of $0.18 (as of 16 minutes into the trading day). The headline reads, “OWC Pharmaceutical Research Corp Completes Development of Its Medical Cannabis Sublingual Tablet”. OWC Pharmaceutical Research…

Oct
18

OWCP: The 12-month Millionaire Maker?

Eye catching headline, right?  Seriously though.  We have yet another eye opening comparison as “evidence” that $2.50/share is not impossible.  Yes, a stock that’s trading at $0.0531/share as of October 17th, 2016 has the potential to reach $2.50 (or beyond).  The question is:…

Oct
14

OWCP: Updated DD on 10/14/16

OWC Pharmaceutical Research Corp. (OTCQB: OWCP) conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. Just after the closing bell on Friday, October 14th, 2016, OWCP released an 8-K (see it…

Oct
11

OWCP: Easy 10 Bagger Potential

If you want evidence of 10 Bagger potential, simply look at $CBIS.  As of October 11th, 2016, $CBIS is trading around $0.02.  Considering they have just shy of 2 BILLION in Outstanding Shares, their market cap is $39.5 million. Do they have substantial…

Oct
8

OWCP: DD on OWC Pharmaceutical Research Corp. (OTCQB: OWCP)

About the Company: OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development of cannabis-based products and…